Sherwin-Williams (NYSE:SHW) PT Lowered to $446.00

Sherwin-Williams (NYSE:SHW) had its target price lowered by analysts at Royal Bank of Canada from $455.00 to $446.00 in a report issued on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the specialty chemicals company’s stock. Royal Bank of Canada’s price target points to a potential upside of 24.22% from the stock’s previous close.

Other equities analysts have also issued reports about the stock. UBS Group restated an “underperform” rating on shares of Sherwin-Williams in a report on Friday, October 18th. StockNews.com upgraded shares of Sherwin-Williams from a “hold” rating to a “buy” rating in a report on Tuesday. Robert W. Baird increased their price target on Sherwin-Williams from $350.00 to $360.00 and gave the company a “neutral” rating in a report on Wednesday. KeyCorp reaffirmed a “sector weight” rating on shares of Sherwin-Williams in a report on Monday, October 7th. Finally, Citigroup lowered their target price on Sherwin-Williams from $430.00 to $420.00 and set a “buy” rating on the stock in a report on Thursday. One analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $395.29.

Sherwin-Williams Stock Down 0.7 %

Shares of NYSE SHW opened at $359.04 on Thursday. The firm has a fifty day simple moving average of $371.91 and a two-hundred day simple moving average of $334.83. Sherwin-Williams has a 12 month low of $232.06 and a 12 month high of $392.57. The company has a current ratio of 0.83, a quick ratio of 0.50 and a debt-to-equity ratio of 1.97. The firm has a market capitalization of $91.03 billion, a PE ratio of 38.28, a price-to-earnings-growth ratio of 2.87 and a beta of 1.17.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 EPS for the quarter, missing analysts’ consensus estimates of $3.56 by ($0.19). The business had revenue of $6.16 billion for the quarter, compared to the consensus estimate of $6.20 billion. Sherwin-Williams had a net margin of 11.09% and a return on equity of 74.45%. The business’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter last year, the firm posted $3.20 EPS. Equities analysts expect that Sherwin-Williams will post 11.31 earnings per share for the current year.

Insider Activity at Sherwin-Williams

In other news, CFO Allen J. Mistysyn sold 14,520 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $366.83, for a total value of $5,326,371.60. Following the completion of the sale, the chief financial officer now directly owns 63,520 shares of the company’s stock, valued at $23,301,041.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. HHM Wealth Advisors LLC raised its position in Sherwin-Williams by 102.3% in the 2nd quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 45 shares during the period. Semmax Financial Advisors Inc. increased its holdings in Sherwin-Williams by 136.4% during the 2nd quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock worth $31,000 after purchasing an additional 60 shares during the period. VitalStone Financial LLC raised its position in Sherwin-Williams by 233.3% during the 2nd quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 77 shares in the last quarter. GHP Investment Advisors Inc. lifted its holdings in shares of Sherwin-Williams by 47.5% in the 3rd quarter. GHP Investment Advisors Inc. now owns 87 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 28 shares during the period. Finally, Anfield Capital Management LLC purchased a new stake in shares of Sherwin-Williams in the 2nd quarter worth $38,000. Institutional investors own 77.67% of the company’s stock.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.